Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. de Marco, S. Accordini, I. Cerveri, A. Corsico, M. Bugiani, J. M. Anto, S. Chinn, T. Gislason, C. Janson, D. Jarvis, F. Neukirch, J. Sunyer, P. Burney, on behalf of the ECRHS II Steering Committee (Verona, Italy). Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II. Eur Respir J 2005; 26: Suppl. 49, 2793

Member's Comments

No comment yet.

Related content which might interest you: Stage 0 in GOLD does not predict future clinical COPD Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002 Validation of non-spirometric predictors of COPD to the GOLD stage classification Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002 Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 GOLD classification of COPD and subsequent mortality: findings from a cohort study Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004 Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006 Prediction of the clinical course of COPD using the old and the new GOLD classification Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Total mortality risks in relation to the GOLD stages in a long term follow-up - a special analysis of GOLD stage 0 Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004 High prevalence of osteoporosis in COPD patients independent of GOLD stage Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Discovery of novel disease-related biomarkers for GOLD stage II COPD: A prospective exploratory clinical study Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Impact of symptomatology in patients with GOLD stage I COPD Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 The effect of changing GOLD severity stage on long-term mortality in COPD Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 GOLD classification of COPD and incident lung cancer: findings from a cohort study Source: Eur Respir J 2004; 24: Suppl. 48, 269s Year: 2004